Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

NCT01900899 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
184
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer